Antigenic and immunogenic properties of inactivated polio vaccine made from Sabin strains

Vaccine

Volumn 17, Issue 15-16, 1999, Pages 2059-2066

  Kersten, Gideon ^a   Hazendonk, Ton ^a   Beuvery, Coen ^a  

^a NATIONAL INSTITUTE FOR PUBLIC HEALTH AND THE ENVIRONMENT   (Netherlands)

Author keywords

Inactivated polio vaccine; Potency; Sabin

Indexed keywords

INACTIVATED VACCINE; ORAL POLIOMYELITIS VACCINE; POLIOMYELITIS VACCINE;

ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; DRUG ANTIGENICITY; DRUG POTENCY; DRUG STABILITY; IMMUNOGENICITY; NONHUMAN; PRIORITY JOURNAL; RAT; STRAIN DIFFERENCE; THERMOSTABILITY; VACCINE PRODUCTION; VIRUS STRAIN;

ADSORPTION; ANIMALS; ANTIBODIES, VIRAL; ANTIGENS, VIRAL; BIOSENSING TECHNIQUES; CERCOPITHECUS AETHIOPS; DRUG STABILITY; ENZYME-LINKED IMMUNOSORBENT ASSAY; GLASS; NEUTRALIZATION TESTS; POLIOVIRUS; POLIOVIRUS VACCINE, INACTIVATED; POLIOVIRUS VACCINE, ORAL; RATS; RATS, WISTAR; SILICON; VACCINES, INACTIVATED; VERO CELLS;

EID: 0033537859     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0264-410X(98)00409-5     Document Type: Article

References (16)

1. Murdin A.D., Barreto L., Plotkin S. Inactivated poliovirus vaccine: past and present experience. Vaccine. 14:1996;735-746.
2. WHO Collaborative Study Group on Oral and Inactivated Poliovirus Vaccines Combined immunization of infants with oral and inactivated poliovirus vaccines: Results of a randomized trial in the Gambia, Oman and Thailand. Bulletin of the World Health Organization. 74:1996;253-268.
3. Halsey N.A., Chesney P.J., Gerber M.A., Gromisch D.S., Kohl S., Marcy S.M., Marks M.I., Murray D.L., Overall J.C., Pickering L.K., Whitley R.J., Yogev R., Peter G., Hall C.B., Breiman R., Hardegree M.C., Jacobs R.F., Orenstein W.A., Rabinovich N.R., Schwartz B. Poliomyelitis prevention: recommendations for use of inactivated poliovirus vaccine and live oral poliovirus vaccine. Pediatrics. 99:1997;300-305.
4. Wood D.J., Heath A.B., Sawyer L.A. A WHO collaborative study on assays of the antigenic content of inactivated poliovirus vaccines. Biologicals. 23:1995;83-94.
5. Wood D.J., Heath A.B. A WHO collaborative study of immunogenicity assays of inactivated poliovirus vaccines. Biologicals. 23:1995;301-311.
6. Sawyer L.A., Mcinnis J., Albrecht P. Quantitation of D antigen content in inactivated poliovirus vaccine derived from wild-type or Sabin strains. Biologicals. 21:1993;169-177.
7. Sawyer L.A., Wood D., Ferguson M., Crainic R., Beuvery E.C., Mcinnis J., Albrecht P. Potency of wild-type or Sabin trivalent inactivated poliovirus vaccine, by enzyme-linked immunosorbent assay using monoclonal antibodies specific for each antigenic site. Biologicals. 25:1997;299-306.
8. Wezel van A.L., Steenis van G., Hannik C.A., Cohen H. New approach to the production of concentrated and purified inactivated polio and rabies tissue culture vaccines. Developments in Biological Standardisation. 41:1978;159-168.
9. Wezel van A.L., Herwaarden van J.A.M., Heuvel-de Rijk van de E.W. Large-scale concentration and purification of virus suspension from microcarrier culture for the preparation of inactivated virus vaccines. Developments in Biological Standardization. 42:1979;65-69.
10. Wood D.J., Heath A.B., Kersten G.F.A., Hazendonk T., Lantinga M., Beuvery E.C. A new WHO international reference reagent for use in potency assays of inactivated poliomyelitis vaccine. Biologicals. 25:1997;59-64.
11. Steenis van G., Wezel van A.L., Sekhuis V.M. Potency testing of killed polio vaccine in rats. Developments in Biological Standardization. 47:1981;119-128.
12. Albrecht P., Steenis van G., Wezel van A.L. Standardization of poliovirus neutralizing antibody test. Reviews in Infectious Diseases. 6:1984;S540.
13. Dernick R. Antigenic structure of poliovirus. Developments in Biological Standardization. 47:1980;319-333.
14. Heukeshoven J., Dernick R. Chemische Analyse und Struktur des Poliovirus. I. Cystein/Cytin Gehalt, vollständige Aminosäureanalyse und Hydrophobizität von Poliovirus und seinen natürlichen leeren Kapsiden. Z. Naturforsch. 36:1981;164-172.
15. Koch F, Koch G. The molecular biology of poliovirus. Wien, New York: Springer Verlag, 1985.
16. Murph J.R., Grose C., Mcandrew P., Mickiewicz C., Mento S., Cano F., Radick L., Ritchey M., Stout M. Sabin inactivated trivalent poliovirus vaccine: first clinical trial and seroimmunity survey. Pediatric Infectious Diseases Journal. 7:1988;760-765.